Chemomab Therapeutics Ltd. Liquidation Value
CMMB
Other
Cash & Equivalents
$20.77M
As of 2023-03-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $20.77M
Total Obligations: -$7.17M
$13.59M
Per share: $0.06
Period: 2023-03-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $20.77M
AR: $0
Total Obligations: -$7.17M
$13.59M
Per share: $0.06
Period: 2023-03-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $20.77M
AR: $0
Inventory: $0
Total Obligations: -$7.17M
$13.59M
Per share: $0.06
Period: 2023-03-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $13.59M | $0.06 |
| Liquid Liquidation Value | $13.59M | $0.06 |
| Operating Liquidation Value | $13.59M | $0.06 |
Key Components (as of 2023-03-31)
| Cash & Equivalents | $20.77M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $7.00M |
| Long-term Debt | N/A |
| Op. Lease Liability | $177,000 |
| Finance Lease | N/A |
| Shares Outstanding | 232.6M |
Explore all 115 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $20.77M | N/A | N/A | N/A | $7.00M | N/A | $177,000 | N/A |
| 2022-12-31 | $13.52M | N/A | N/A | N/A | $6.75M | N/A | $214,000 | N/A |
| 2022-09-30 | $10.74M | N/A | N/A | N/A | $5.48M | N/A | $244,000 | N/A |
| 2022-06-30 | $9.88M | N/A | N/A | N/A | $4.39M | N/A | $280,000 | N/A |
| 2022-03-31 | $13.83M | N/A | N/A | N/A | $3.52M | N/A | $319,000 | N/A |
| 2021-12-31 | $15.19M | N/A | N/A | N/A | $2.65M | N/A | $343,000 | N/A |
| 2021-09-30 | $37.74M | N/A | N/A | N/A | $1.63M | N/A | $359,000 | N/A |
| 2021-06-30 | $45.40M | N/A | N/A | N/A | $2.16M | N/A | $392,000 | N/A |
▼ Community Notes